Xylem Toekomstige groei
Future criteriumcontroles 1/6
Xylem zal naar verwachting groeien in winst en omzet met respectievelijk 14.1% en 4.9% per jaar. De winst per aandeel zal naar verwachting groeien met 14.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 11.3% zijn.
Belangrijke informatie
14.1%
Groei van de winst
14.6%
Groei van de winst per aandeel
Machinery winstgroei | 8.7% |
Inkomstengroei | 4.9% |
Toekomstig rendement op eigen vermogen | 11.3% |
Dekking van analisten | Good |
Laatst bijgewerkt | 11 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
An Intrinsic Calculation For Xylem Inc. (NYSE:XYL) Suggests It's 25% Undervalued
Nov 19Xylem: Healthy Dividend Growth With Strong Long-Term Tailwinds
Nov 04Xylem Inc. (NYSE:XYL) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 03Investors Still Waiting For A Pull Back In Xylem Inc. (NYSE:XYL)
Oct 23Xylem: Good Performance Likely To Be Fully Priced In
Sep 07At US$136, Is It Time To Put Xylem Inc. (NYSE:XYL) On Your Watch List?
Aug 30Xylem (NYSE:XYL) Could Easily Take On More Debt
Aug 15Do Xylem's (NYSE:XYL) Earnings Warrant Your Attention?
Jul 31Calculating The Fair Value Of Xylem Inc. (NYSE:XYL)
Jul 17What You Can Learn From Xylem Inc.'s (NYSE:XYL) P/E
Jul 04Xylem: Wait For Multiple Contraction For This Excellent Company
Jun 21Is Now The Time To Look At Buying Xylem Inc. (NYSE:XYL)?
May 23There May Be Underlying Issues With The Quality Of Xylem's (NYSE:XYL) Earnings
May 10Is Xylem (NYSE:XYL) Using Too Much Debt?
May 07Is Now The Time To Put Xylem (NYSE:XYL) On Your Watchlist?
Apr 24Xylem: Bigger Does Not Mean Better Shareholder Value
Apr 04With Xylem Inc. (NYSE:XYL) It Looks Like You'll Get What You Pay For
Mar 28Calculating The Fair Value Of Xylem Inc. (NYSE:XYL)
Mar 14Xylem: Fund Managers Like This Top ESG-Rated Stock
Jan 22Should You Think About Buying Xylem Inc. (NYSE:XYL) Now?
Dec 12Xylem: Good Prospects, But Pricey
Nov 09With EPS Growth And More, Xylem (NYSE:XYL) Makes An Interesting Case
Nov 09Xylem: Overvalued Stock Despite An Interesting Merger
Oct 24Estimating The Fair Value Of Xylem Inc. (NYSE:XYL)
Oct 24These 4 Measures Indicate That Xylem (NYSE:XYL) Is Using Debt Reasonably Well
Sep 12Xylem Is A Good Buy At The Current Levels
Aug 18When Should You Buy Xylem Inc. (NYSE:XYL)?
Aug 04Is Xylem (NYSE:XYL) Using Too Much Debt?
Jun 09Xylem: A Pure Water Play
Jun 09Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 9,407 | 1,157 | 1,250 | 1,694 | 15 |
12/31/2025 | 8,928 | 992 | 1,142 | 1,562 | 20 |
12/31/2024 | 8,491 | 790 | 1,001 | 1,338 | 19 |
9/30/2024 | 8,424 | 830 | 828 | 1,143 | N/A |
6/30/2024 | 8,396 | 765 | 890 | 1,205 | N/A |
3/31/2024 | 7,949 | 663 | 649 | 945 | N/A |
12/31/2023 | 7,364 | 609 | 566 | 837 | N/A |
9/30/2023 | 6,752 | 492 | 507 | 744 | N/A |
6/30/2023 | 6,056 | 352 | 357 | 573 | N/A |
3/31/2023 | 5,698 | 372 | 450 | 658 | N/A |
12/31/2022 | 5,522 | 355 | 388 | 596 | N/A |
9/30/2022 | 5,339 | 319 | 225 | 454 | N/A |
6/30/2022 | 5,224 | 421 | 141 | 364 | N/A |
3/31/2022 | 5,211 | 422 | 265 | 483 | N/A |
12/31/2021 | 5,195 | 427 | 330 | 538 | N/A |
9/30/2021 | 5,245 | 462 | 514 | 688 | N/A |
6/30/2021 | 5,200 | 385 | 683 | 851 | N/A |
3/31/2021 | 5,009 | 303 | 629 | 800 | N/A |
12/31/2020 | 4,876 | 254 | 641 | 824 | N/A |
9/30/2020 | 4,874 | 224 | 655 | 842 | N/A |
6/30/2020 | 4,950 | 252 | 620 | 812 | N/A |
3/31/2020 | 5,135 | 360 | 546 | 754 | N/A |
12/31/2019 | 5,249 | 401 | 613 | 839 | N/A |
9/30/2019 | 5,264 | 508 | 408 | 649 | N/A |
6/30/2019 | 5,255 | 573 | 336 | 591 | N/A |
3/31/2019 | 5,227 | 549 | 361 | 606 | N/A |
12/31/2018 | 5,207 | 549 | 349 | 586 | N/A |
9/30/2018 | 5,098 | 395 | 473 | 695 | N/A |
6/30/2018 | 5,006 | 370 | N/A | 736 | N/A |
3/31/2018 | 4,853 | 354 | N/A | 697 | N/A |
12/31/2017 | 4,707 | 331 | N/A | 686 | N/A |
9/30/2017 | 4,525 | 310 | N/A | 602 | N/A |
6/30/2017 | 4,227 | 278 | N/A | 523 | N/A |
3/31/2017 | 3,995 | 250 | N/A | 508 | N/A |
12/31/2016 | 3,771 | 260 | N/A | 497 | N/A |
9/30/2016 | 3,670 | 324 | N/A | 478 | N/A |
6/30/2016 | 3,675 | 339 | N/A | 466 | N/A |
3/31/2016 | 3,663 | 342 | N/A | 466 | N/A |
12/31/2015 | 3,653 | 340 | N/A | 464 | N/A |
9/30/2015 | 3,701 | 322 | N/A | 423 | N/A |
6/30/2015 | 3,762 | 340 | N/A | 441 | N/A |
3/31/2015 | 3,847 | 352 | N/A | 433 | N/A |
12/31/2014 | 3,916 | 337 | N/A | 416 | N/A |
9/30/2014 | 3,907 | 309 | N/A | 414 | N/A |
6/30/2014 | 3,909 | 276 | N/A | 360 | N/A |
3/31/2014 | 3,864 | 236 | N/A | 326 | N/A |
12/31/2013 | 3,837 | 228 | N/A | 324 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei XYL ( 14.1% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van XYL ( 14.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.3% per jaar).
Hoge groeiwinsten: De winst van XYL zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van XYL ( 4.9% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van XYL ( 4.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen XYL zal naar verwachting over 3 jaar laag zijn ( 11.3 %).